The transosteal implant: a 17-year review and report.
The survival percentage for the transosteal implant is 80.9% +/- 0.04 and predictably satisfactory host site responses may be anticipated at the 100% level after the second successful year in situ. The benefits of the transosteal implant are its unsophisticated design with a straight uncomplicated cervix, a simple surgical technique, economy, immediate fixation and readiness for use, modesty of size, versatility (it may be used singly or in diverse multiples in association with teeth or other implants), ease of removal when indicated, and universality of application to a broad variety of anatomic and prosthetic situations.